-
Published 7/1/2026
Hsu HE, Lodi S, Yan S, Bovell-Ammon BJ, Christine PJ, Tilhou AS, Bernson D, Novo P, Lee JD, Rotrosen J, Liebschutz JM, Walley AY, Larochelle MR. Buprenorphine-Naloxone vs Extended-Release Naltrexone Following Opioid Withdrawal Treatment. JAMA Netw Open. 2026 Jul 01; 9(7):e2623280. PMID: 42446876.
-
Published 7/1/2026
Hall LC, Donohue JM, LaRochelle M, Rossom RC, Wang X, Afshar M, Gellad WF, Groenwold RHH, Han B, Jones CM, Lo-Ciganic WH, Lodi S, Marshall BDL, McLeman BM, Lambert-Harris CA, Saunders EC, Marsch LA. Methodological innovations to advance substance use disorder research: Proceedings of a NIDA workshop on target trial emulation and translational testing of digital health tools. J Subst Use Addict Treat. 2026 Jul 01; 190:210065. PMID: 42385937.
-
Published 6/23/2026
Adams RS, Reif S, Mohamed Y, Stewart MT, LaRochelle MR, Heaphy D, Corrigan JD, Khorassani FS, Morgan JR. Alcohol use disorder diagnoses among commercially insured US adults from 2016 to 2023, by disability status and sex. Drug Alcohol Depend Rep. 2026 Sep; 20:100461. PMID: 42440433.
-
Published 6/12/2026
Walley AY, Cheng DM, Vandergrift N, Larochelle M, Holloway J, Brown JL, Chandler R, Fanucchi LC, Feaster DJ, Freeman PR, Hunt T, Lofwall MR, Knudsen HK, Nunes EV, Oga E, Oyler DR, Samet JH, Villani J, Walsh SL, Winhusen TJ. The association between naloxone distribution, buprenorphine treatment and retention and incident high-risk opioid prescribing with opioid overdose death in Kentucky, Massachusetts, New York and Ohio, United States: An exploratory community-level cohort study of data from the HEALing Communities Study. Addiction. 2026 Jun 12. PMID: 42283399.
-
Published 4/30/2026
Chhatwal J, Sahinkoc M, Chen Q, Dowd W, Xiao J, Zarkin GA, Aldridge A, Barocas JA, Cerdá M, Fareed N, Frazier LA, Hyder A, Keyes KM, Knott CE, LaRochelle M, Linas BP, Oga E, Roberts SM, Samet JH, Schackman BR, Seiber EE, Starbird LE, Villani J, Knudsen AB, Barbosa C. Cost-effectiveness of community-based interventions for reducing opioid overdose and non-overdose deaths: simulation modeling of HEALing Communities Study. Lancet Reg Health Am. 2026 Jul; 59:101480. PMID: 42099551.